Fig. 9From: Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric CancerAnalysis of GLT8D1/2 genetic alterations. (A, B) Total mutations of GLT8D1 (A) and GLT8D2 (B) in pan-cancer from the cBioPortal database. (C) The alteration frequency of GLT8D1/2 with different mutation types in gastric cancer. (D, E) The association of genetic alterations in GLT8D1 (D) and GLT8D2 (E) with OS prognosis of gastric cancer patients. OS, overall survivalBack to article page